Invesco’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
|
|||||
2025
Q1 | $26.2K | Sell |
|
|||||
2024
Q4 | $31K | Buy |
|
|||||
2024
Q3 | $54.8K | Buy |
|
|||||
2024
Q2 | $56.6K | Buy |
|
|||||
2024
Q1 | $84K | Sell |
|
|||||
2023
Q4 | $62K | Sell |
|
|||||
2023
Q3 | $77.8K | Hold |
|
|||||
2023
Q2 | $92.9K | Buy |
|
|||||
2022
Q2 | – | Sell |
|
|||||
2022
Q1 | $53K | Sell |
|
|||||
2021
Q4 | $103K | Sell |
|
|||||
2021
Q3 | $140K | Buy |
|
|||||
2021
Q2 | $126K | Buy |
|
|||||
2019
Q1 | – | Sell |
|
|||||
2018
Q4 | $31K | Sell |
|
|||||
2018
Q3 | $79K | Sell |
|
|||||
2018
Q2 | $80K | Sell |
|
|||||
2018
Q1 | $287K | Sell |
|
|||||
2017
Q4 | $238K | Sell |
|
|||||
2017
Q3 | $319K | Sell |
|
|||||
2017
Q2 | $356K | Buy |
|
|||||
2015
Q3 | – | Sell |
|
|||||
2015
Q2 | $5K | Buy |
|